GO:0048040 UDP-glucuronate decarboxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048040 (UDP-glucuronate decarboxylase activity) catalyzes the conversion of UDP-alpha-D-glucuronate to UDP-alpha-D-xylose and CO2, a key step in nucleotide sugar interconversion.
• The enzyme is essential for proteoglycan synthesis and cell wall polysaccharide formation in animals and plants.
• In humans, the enzyme is encoded by UXS1, and a monoallelic variant has been linked to short-limbed short stature.
• In cancer, UDP-glucuronate decarboxylase 1 (UXS1) promotes tumor immune evasion by accelerating KMT2D loss in hepatocellular carcinoma.
• The enzyme exists in multiple forms with allosteric properties, as shown in chondrocytes.
• Research tools include CRISPR knockout, point mutation, knock-in, overexpression, and CRISPR library screening to dissect its roles in development and disease.
Description
UDP-glucuronate decarboxylase activity (GO:0048040) is a molecular function that catalyzes the decarboxylation of UDP-alpha-D-glucuronate to produce UDP-alpha-D-xylose and carbon dioxide. This reaction is a critical branch point in nucleotide sugar metabolism, linking glucuronic acid and xylose pools that are required for the biosynthesis of proteoglycans, hemicellulose, and other glycoconjugates. The enzyme was first characterized in cultured chondrocytes, where its activity was shown to be essential for proteoglycan synthesis. Subsequent cloning and characterization of the enzyme from animal sources confirmed its role in UDP-xylose formation. In plants, antisense down-regulation of UDP-glucuronate decarboxylase in tobacco altered hemicellulose content and cellulose extractability, demonstrating its importance in cell wall architecture. The enzyme is also present in Cryptococcus neoformans, where it is involved in capsular polysaccharide synthesis. In humans, the gene encoding this activity is UXS1, and a monoallelic variant has been associated with short-limbed short stature. More recently, UXS1 has been implicated in tumor immune evasion in hepatocellular carcinoma, highlighting its potential as a therapeutic target. Given its central role in glycosylation and development, understanding the regulation and function of UDP-glucuronate decarboxylase activity is of broad interest to researchers in glycobiology, cancer biology, and plant science.
UDP-glucuronate decarboxylase activity At A Glance
| GO ID | GO:0048040 |
|---|---|
| GO term | UDP-glucuronate decarboxylase activity |
| Ontology | molecular_function |
| Synonym | UDP-D-glucuronate carboxy-lyase activity; UDP-D-glucuronate carboxy-lyase (UDP-D-xylose-forming); UDPglucuronate decarboxylase activity; UDP-glucuronic acid decarboxylase activity; uridine-diphosphoglucuronate decarboxylase activity |
| Definition | Catalysis of the reaction: H+ + UDP-alpha-D-glucuronate = CO2 + UDP-alpha-D-xylose. |
| Major function | Conversion of UDP-glucuronic acid to UDP-xylose, essential for proteoglycan and cell wall polysaccharide synthesis. |
| EC number | 4.1.1.35 |
| Reaction direction | Decarboxylation (irreversible under physiological conditions) |
| Subcellular location | Golgi apparatus (animal cells); Golgi/endoplasmic reticulum (plant cells) |
What Is GO:0048040?
UDP-glucuronate decarboxylase activity (GO:0048040) is defined as the catalysis of the reaction: H+ + UDP-alpha-D-glucuronate = CO2 + UDP-alpha-D-xylose. In other words, it removes a carboxyl group from UDP-glucuronic acid to form UDP-xylose, a key nucleotide sugar donor for xylosylation reactions. This activity is synonymous with UDP-D-glucuronate carboxy-lyase activity, UDP-D-glucuronate carboxy-lyase (UDP-D-xylose-forming), UDPglucuronate decarboxylase activity, UDP-glucuronic acid decarboxylase activity, and uridine-diphosphoglucuronate decarboxylase activity.
Why Is UDP-glucuronate decarboxylase activity Important in Cell Biology?
UDP-glucuronate decarboxylase activity is a key enzymatic step in the interconversion of nucleotide sugars, providing UDP-xylose for the biosynthesis of glycosaminoglycans, proteoglycans, and plant cell wall polysaccharides. Its importance is underscored by its evolutionary conservation and its involvement in human disease: a monoallelic variant in UXS1 causes short-limbed short stature, and UXS1 promotes tumor immune evasion in hepatocellular carcinoma. In plants, manipulation of this activity alters hemicellulose content and cellulose extractability, with implications for biofuel production and crop improvement. Thus, understanding this enzyme is relevant to developmental biology, cancer research, glycobiology, and plant biotechnology.
• Essential for proteoglycan synthesis in chondrocytes and other connective tissues.
• Required for capsular polysaccharide formation in Cryptococcus neoformans, a fungal pathogen.
• Modulates hemicellulose content and cellulose extractability in plants.
• Linked to short-limbed short stature in humans through UXS1 variants.
• Promotes tumor immune evasion in hepatocellular carcinoma via KMT2D loss.
• Exhibits allosteric regulation, with multiple enzyme forms in chondrocytes.
• Serves as a branch point between glucuronic acid and xylose metabolism.
• Potential target for cancer immunotherapy and metabolic engineering.
• Involved in plant cell wall biosynthesis and biomass recalcitrance.
• Provides a model for studying nucleotide sugar interconversion and Golgi function.
What Happens During UDP-glucuronate decarboxylase activity?
Substrate binding and decarboxylation
In simple terms: The enzyme grabs UDP-glucuronic acid and removes a carboxyl group from it.
UDP-glucuronate decarboxylase binds UDP-alpha-D-glucuronate and catalyzes the removal of the C6 carboxyl group as CO2, yielding UDP-alpha-D-xylose. This reaction is a decarboxylation that does not require ATP or other energy sources, and it is essentially irreversible under physiological conditions. The enzyme was first detected in cultured chondrocytes, where its activity was shown to be necessary for proteoglycan synthesis.
Formation of UDP-xylose
In simple terms: The product, UDP-xylose, is a sugar donor used to build complex carbohydrates.
The immediate product of the reaction is UDP-alpha-D-xylose, which serves as the xylose donor for xylosyltransferases in the Golgi apparatus. UDP-xylose is required for the synthesis of glycosaminoglycans such as chondroitin sulfate and heparan sulfate, as well as for plant hemicellulose. In plants, the pathway from UDP-glucose to UDP-xylose involves UDP-glucuronate decarboxylase as a key step, and its expression is regulated during tissue differentiation.
Allosteric regulation and multiple forms
In simple terms: The enzyme can exist in different forms that respond to cellular signals.
Two forms of UDP-glucuronate carboxy-lyase were separated from chondrocytes, and they exhibited allosteric properties, suggesting that enzyme activity can be modulated by metabolites. This regulation may allow cells to adjust UDP-xylose production according to demand for proteoglycan synthesis. The presence of multiple forms may also reflect post-translational modifications or alternative splicing, though this requires further study.
Role in cell wall and matrix biosynthesis
In simple terms: The enzyme provides building blocks for the extracellular matrix in animals and the cell wall in plants.
In animal cells, UDP-xylose produced by this enzyme is used for proteoglycan synthesis, which is essential for cartilage and connective tissue. In plants, antisense down-regulation of UDP-glucuronate decarboxylase in tobacco reduced hemicellulose content and altered cellulose extractability, demonstrating its role in cell wall architecture. The enzyme is also involved in the synthesis of capsular polysaccharide in Cryptococcus neoformans, contributing to fungal virulence.
Key Genes Involved in GO:0048040 UDP-glucuronate decarboxylase activity
The following genes and proteins are directly associated with UDP-glucuronate decarboxylase activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UXS1 (human) | Encodes UDP-glucuronate decarboxylase 1, catalyzing UDP-xylose formation | Linked to short-limbed short stature and tumor immune evasion |
| UXS2 (human) | Paralog of UXS1, may have redundant or distinct functions | Potential compensation in UXS1 deficiency; not yet fully characterized |
| Uxs1 (mouse) | Ortholog of human UXS1, involved in proteoglycan synthesis | Model for skeletal development and glycosylation disorders |
| Uxs1 (Drosophila) | Required for glycosaminoglycan biosynthesis | Genetic studies of morphogen gradients and development |
| UXS1 (Arabidopsis) | Involved in UDP-xylose production for cell wall polysaccharides | Model for plant cell wall engineering |
| UXS2 (Arabidopsis) | Paralog with potential tissue-specific roles | Functional redundancy in hemicellulose synthesis |
| UXS3 (Arabidopsis) | Additional isoform contributing to UDP-xylose pool | Stress responses and cell wall remodeling |
| UXS4 (Arabidopsis) | Isoform expressed in specific tissues | Root hair development and polysaccharide composition |
| UXS5 (Arabidopsis) | Isoform with distinct kinetic properties | Fine-tuning of nucleotide sugar pools |
| UXS6 (Arabidopsis) | Isoform involved in vascular development | Xylem formation and biomass production |
| Cryptococcus neoformans UXS1 | Required for capsular polysaccharide synthesis | Fungal virulence and drug target |
| Chondrocyte UXS | Enzyme activity essential for proteoglycan synthesis | Cartilage biology and osteoarthritis research |
| KMT2D | Histone methyltransferase, loss accelerated by UXS1 | Tumor immune evasion in hepatocellular carcinoma |
| UDP-glucose dehydrogenase | Produces UDP-glucuronate, upstream of UXS1 | Metabolic flux control |
| UDP-xylose synthase | Alternative name for UXS1 | Enzyme kinetics and structure-function studies |
| Xylosyltransferase | Uses UDP-xylose for glycosaminoglycan synthesis | Downstream effector of UXS1 |
| Golgi apparatus | Subcellular location of UXS1 activity | Membrane trafficking and glycosylation |
| Nucleotide sugar transporters | Import UDP-glucuronate into Golgi | Supply substrate for UXS1 |
How Is UDP-glucuronate decarboxylase activity Regulated?
UDP-glucuronate decarboxylase activity is regulated at multiple levels. In chondrocytes, two forms of the enzyme with allosteric properties were identified, suggesting feedback regulation by metabolites such as UDP-xylose or UDP-glucuronate. In plants, expression of UDP-glucuronate decarboxylase genes is developmentally regulated during tissue differentiation, with distinct isoforms showing tissue-specific expression patterns. Antisense down-regulation in tobacco altered hemicellulose content, indicating that enzyme levels directly influence cell wall composition. In cancer, UXS1 expression promotes tumor immune evasion by accelerating KMT2D loss, though the upstream regulators of UXS1 in this context remain to be fully elucidated. Overall, regulation occurs at transcriptional, post-transcriptional, and allosteric levels, allowing fine-tuning of UDP-xylose production.
UDP-glucuronate decarboxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UXS1 | Short-limbed short stature | Knock-in mouse model with patient variant |
| UXS1 | Hepatocellular carcinoma immune evasion | Xenograft or orthotopic liver cancer model with UXS1 knockout |
| Cryptococcus neoformans UXS1 | Fungal virulence | Fungal knockout strains in infection models |
| Arabidopsis UXS genes | Altered cell wall composition | Antisense or CRISPR knockout plants |
| Chondrocyte UXS | Proteoglycan synthesis defects | Primary chondrocyte cultures and cartilage explants |
Short-limbed short stature
A monoallelic variant in UXS1 has been associated with short-limbed short stature, highlighting the critical role of UDP-glucuronate decarboxylase activity in skeletal development. This condition likely results from impaired proteoglycan synthesis in cartilage, leading to abnormal bone growth. The identification of this variant underscores the importance of UDP-xylose production for normal skeletal morphogenesis.
Hepatocellular carcinoma and immune evasion
UDP-glucuronate decarboxylase 1 (UXS1) promotes tumor immune evasion by accelerating KMT2D loss in hepatocellular carcinoma. This suggests that UXS1 may be a therapeutic target to enhance anti-tumor immunity. The mechanism involves metabolic reprogramming that affects histone methylation and gene expression, linking glycosylation to epigenetic regulation.
Fungal infections
In Cryptococcus neoformans, UDP-glucuronate decarboxylase is required for capsular polysaccharide synthesis, which is a major virulence factor. Inhibiting this enzyme could reduce fungal pathogenicity, making it a potential antifungal target.
Plant cell wall disorders and biomass
Alterations in UDP-glucuronate decarboxylase activity in plants affect hemicellulose content and cellulose extractability, which are important for biomass conversion and crop quality. This has implications for biofuel production and plant resilience.
From UDP-glucuronate decarboxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does UXS1 loss affect skeletal development? | UXS1 knockout mouse (conditional or global) |
| Does the patient variant cause short stature? | UXS1 point-mutation knock-in mouse |
| Can UXS1 be targeted for cancer immunotherapy? | UXS1 knockout in syngeneic tumor models |
| What is the subcellular localization of UXS1? | Tagged knock-in (e.g., GFP) in cell lines |
| Does UXS1 overexpression alter glycosaminoglycan profiles? | UXS1 overexpression in chondrocytes or fibroblasts |
| What genes interact with UXS1 in plants? | CRISPR library screening in Arabidopsis |
How to Study the UDP-glucuronate decarboxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive CO2 release assay | Enzymatic decarboxylation activity | Kinetic studies and inhibitor screening |
| HPLC-based UDP-xylose detection | Product formation | Enzyme purification and characterization |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Cancer target discovery |
| RNA-seq | Transcript levels of UXS genes | Tissue-specific expression and regulation |
| Proteomics | Protein abundance and modifications | Post-translational regulation |
| Glycomics (LC-MS) | Glycosaminoglycan composition | Impact of UXS1 variants on proteoglycans |
| Immunofluorescence | Subcellular localization | Golgi localization of UXS1 |
| Plant transformation | Cell wall composition | Antisense or overexpression in tobacco |
Enzymatic assays
UDP-glucuronate decarboxylase activity can be measured using radiolabeled UDP-glucuronic acid and detecting the release of 14CO2 or the formation of UDP-xylose by HPLC or mass spectrometry. These assays are essential for kinetic characterization and inhibitor screening.
CRISPR-based genetic screens
CRISPR knockout libraries can be used to identify genes that modulate UDP-glucuronate decarboxylase activity or its downstream effects. For example, a genome-wide screen in cancer cells could reveal synthetic lethal interactions with UXS1.
Transcriptomics and proteomics
RNA-seq and proteomics can quantify UXS1 expression across tissues and conditions, revealing regulatory mechanisms. In plants, transcript profiling of UXS isoforms during differentiation has provided insights into tissue-specific roles.
Glycan analysis
Mass spectrometry-based glycomics can assess the impact of UXS1 manipulation on glycosaminoglycan and proteoglycan structures. This is particularly useful for evaluating the consequences of point mutations or knockouts.
How CRISPR Can Be Used to Study GO:0048040 UDP-glucuronate decarboxylase activity
Knockout
CRISPR knockout of UXS1 can be used to study its essential role in proteoglycan synthesis and skeletal development. In cancer cell lines, UXS1 knockout can reverse immune evasion and sensitize tumors to immunotherapy. In plants, knockout of UXS genes can reveal their contributions to cell wall polysaccharide biosynthesis.
Point Mutation
Introducing the patient-associated point mutation into UXS1 via CRISPR can model short-limbed short stature and elucidate the molecular basis of the disease. Such models can also be used to test pharmacological chaperones or substrate analogs.
Knock-in
Knock-in of a fluorescent tag (e.g., GFP) at the endogenous UXS1 locus allows real-time tracking of enzyme localization and dynamics in living cells. This approach can reveal how UXS1 traffics to the Golgi and responds to metabolic cues.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase UXS1 levels to study its effects on glycosaminoglycan production and tumor immune evasion. Overexpression in chondrocytes can enhance proteoglycan synthesis and may have therapeutic potential for cartilage repair.
How EDITGENE Supports UDP-glucuronate decarboxylase activity Research
Researchers studying UDP-glucuronate decarboxylase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for UDP-glucuronate decarboxylase activity research.
Frequently Asked Questions About UDP-glucuronate decarboxylase activity
What is UDP-glucuronate decarboxylase activity?
UDP-glucuronate decarboxylase activity (GO:0048040) is the enzymatic conversion of UDP-alpha-D-glucuronate to UDP-alpha-D-xylose and CO2, a key step in nucleotide sugar metabolism.
What genes are involved in UDP-glucuronate decarboxylase activity?
The primary gene is UXS1 in humans, with orthologs in other species such as Uxs1 in mice and UXS genes in plants.
What diseases are associated with UDP-glucuronate decarboxylase activity?
Mutations in UXS1 are linked to short-limbed short stature, and UXS1 promotes tumor immune evasion in hepatocellular carcinoma.
How is UDP-glucuronate decarboxylase activity regulated?
It is regulated by allosteric mechanisms, developmental cues, and transcriptional control, with multiple enzyme forms in chondrocytes.
What is the role of UDP-glucuronate decarboxylase in plants?
It is essential for hemicellulose and cell wall polysaccharide synthesis, affecting cellulose extractability and biomass.
Can UDP-glucuronate decarboxylase be targeted for cancer therapy?
Yes, UXS1 promotes immune evasion in hepatocellular carcinoma, and its inhibition could enhance anti-tumor immunity.
What methods are used to study UDP-glucuronate decarboxylase activity?
Enzymatic assays, CRISPR screens, RNA-seq, proteomics, and glycomics are commonly used.
What is the subcellular localization of UDP-glucuronate decarboxylase?
It is localized to the Golgi apparatus in animal cells, where it produces UDP-xylose for glycosylation.
Are there multiple forms of UDP-glucuronate decarboxylase?
Yes, two forms with allosteric properties have been separated from chondrocytes.
How can CRISPR be used to study UDP-glucuronate decarboxylase activity?
CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models enable functional studies in cells and organisms.
Conclusion
UDP-glucuronate decarboxylase activity (GO:0048040) is a fundamental enzymatic function that bridges glucuronic acid and xylose metabolism, impacting proteoglycan synthesis, plant cell wall formation, and human disease. Its role in skeletal development and cancer immune evasion highlights its clinical relevance. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate its regulatory mechanisms and therapeutic potential.
References
- 1. Zhang J et al.. 2026. UDP-glucuronate decarboxylase 1 promotes tumor immune evasion by accelerating KMT2D loss in hepatocellular carcinoma.. J Immunother Cancer 14(7) PMID: 42419879
- 2. Moriarity JL et al.. 2002. UDP-glucuronate decarboxylase, a key enzyme in proteoglycan synthesis: cloning, characterization, and localization.. J Biol Chem 277(19):16968-75 PMID: 11877387
- 3. John KV et al.. 1977. UDP-glucuronate carboxy-lyase in cultured chondrocytes.. J Biol Chem 252(19):6707-10 PMID: 197101
- 4. Jacobson ES et al.. 1982. UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans.. J Bacteriol 152(2):932-4 PMID: 6752126
- 5. Bindschedler LV et al.. 2007. Modification of hemicellulose content by antisense down-regulation of UDP-glucuronate decarboxylase in tobacco and its consequences for cellulose extractability.. Phytochemistry 68(21):2635-48 PMID: 17920089
- 6. Rustad CF et al.. 2024. A monoallelic UXS1 variant associated with short-limbed short stature.. Mol Genet Genomic Med 12(6):e2472 PMID: 38860481
- 7. John KV et al.. 1977. Separation and allosteric properties of two forms of UDP-glucuronate carboxy-lyase.. J Biol Chem 252(22):8013-7 PMID: 914860
- 8. Bindschedler LV et al.. 2005. Characterisation and expression of the pathway from UDP-glucose to UDP-xylose in differentiating tobacco tissue.. Plant Mol Biol 57(2):285-301 PMID: 15821883
